GlassScriptPhysician profile
Jodi Steinbrenner
NPI 1902350622
$2,832.66
in general payments reported to CMS, 2019-2025
23 companies · $1,187 in 2025
The $1,187 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $107 · 2023: $355 · 2024: $1,017 · 2025: $1,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,361 · Travel and Lodging: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.29 |
| Travel and Lodging | $1,197.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $1,453.11 | 2024-2025 | Theragenesis Wound Matrix |
| Convatec INC. | $316.10 | 2021-2025 | |
| Solventum Corporation | $207.49 | 2024-2025 | Prevena, V.A.C.Instill, Abthera |
| Melinta Therapeutics, LLC | $133.10 | 2023 | Kimyrsa, Rezzayo, Orbactiv |
| Hollister Incorporated | $107.06 | 2022 | |
| Mindray Ds USA, INC. | $96.67 | 2024 | A7 Anesthesia System |
| Bsn Medical INC | $68.57 | 2023 | |
| Merck Sharp & Dohme LLC | $46.01 | 2025 | Zerbaxa |
| Integra Lifesciences Corporation | $39.38 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aroa Biosurgery Incorporated | $38.51 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $35.86 | 2024-2025 | Eliquis, Camzyos |
| Tactile Systems Technology INC | $34.74 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Cashflow Solutions, LLC | $31.89 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Misonix INC | $29.45 | 2021 | |
| Smith+Nephew, INC. | $28.56 | 2025 | Collagenase Santyl |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $28.04 | 2023 | Xarelto |
| Ascendis Pharma Endocrinology INC | $26.81 | 2025 | Yorvipath |
| Kci USA, INC. | $22.86 | 2021 | |
| Rgh Enterprises LLC | $22.78 | 2024 | |
| Molnlycke Health Care US, LLC | $19.21 | 2024 | Exufiber Ag+, Mextra Superabsorbant, Tubifast |
| Actelion Pharmaceuticals US, INC. | $15.82 | 2024 | Opsumit |
| Seagen INC. | $15.39 | 2023 | Tukysa |
| Hartmann USA, INC. | $15.25 | 2024 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Steinbrenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.